| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $10.7M | -32.0% |
| SG&A Expense | $16.3M | +15.9% |
| Operating Income | -$27.0M | +9.3% |
| Income Tax | $53K | +657.1% |
| Net Income | -$44.3M | +46.6% |
| EPS (Basic) | -$1.54 | +71.4% |
| EPS (Diluted) | -$1.54 | +71.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $106K | +307.7% |
| Current Assets | $2.5M | +27.4% |
| Total Assets | $16.2M | -1.5% |
| Current Liabilities | $58.0M | +46.9% |
| Total Liabilities | $86.1M | +14.6% |
| Stockholders' Equity | -$69.9M | -19.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.9M | +4.9% |
| Investing Cash Flow | -$13K | +72.9% |
| Financing Cash Flow | $20.9M | -5.9% |